Europe
Renowned fund manager and buyside analyst joins investor relations and strategic communications specialists
MHRA confirms GLP extension at Dundee and Bradford sites
AstraZeneca is attempting to find encouraging news in the failure of its MYSTIC clinical trial, but it doesn’t look good.
Expedeon’s proprietary immunoassay technology to be incorporated into Quanterix’ Simoa Planar Immunoassay products
Ability Pharmaceuticals announced today that it has received orphan-drug designation (ODD) for ABTL0812 from the US Food and Drug administration (FDA) for the treatment of biliary tract cancer.
Epigenomics AG today announced its financial results for the third quarter and the nine months 2018 ending September 30.
Modus Therapeutics AB announces that the FDA has accepted its sevuparin IND for the treatment of SCD.
Winner SunRegen Healthcare is focused on innovative treatments for patients with neurodegenerative eye diseases
Positive preclinical results presented at ESMO
Provides students with the opportunity to design new drug-like molecules targeting fibrotic diseases and malaria with cutting-edge drug discovery software
PRESS RELEASES